Differential thermostability and response to cystic fibrosis transmembrane conductance regulator (CFTR) potentiators of human and mouse F508del-CFTR
Cross-species comparative studies have highlighted differences between human and mouse cystic fibrosis transmembrane conductance regulator (CFTR), the epithelial Cl− channel defective in cystic fibrosis (CF). Here, we compare the impact of the most common CF mutation F508del on the function of human...
Main Authors: | Bose, S, Bijvelds, M, Wang, Y, Liu, J, Cai, Z, Bot, A, De Jonge, H, Sheppard, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Physiological Society
2019
|
Similar Items
-
Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024) -
Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6.
by: Siegel, D, et al.
Published: (1992) -
Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
by: Hyde, S
Published: (2013) -
A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016) -
N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
by: Désiré, J, et al.
Published: (2014)